These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33715138)

  • 21. UK interventions to control medicines wastage: a critical review.
    White KG
    Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant utilization in primary care in a Spanish region: impact of generic and reference-based pricing policy (2000-2004).
    Ubeda A; Cardo E; Sellés N; Broseta R; Trillo JL; Fernández-Llimós F
    Soc Psychiatry Psychiatr Epidemiol; 2007 Mar; 42(3):181-8. PubMed ID: 17235443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in psychotropic drug consumption among French military personnel during the COVID-19 epidemic.
    Sanchez MA; Fuchs B; Tubert-Bitter P; Mariet AS; Jollant F; Mayet A; Quantin C
    BMC Med; 2022 Sep; 20(1):306. PubMed ID: 36100914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic.
    Tiger M; Castelpietra G; Wesselhoeft R; Lundberg J; Reutfors J
    Transl Psychiatry; 2024 Apr; 14(1):175. PubMed ID: 38575574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in antidepressant use in Australia: A nationwide analysis (2015-2021).
    de Oliveira Costa J; Gillies MB; Schaffer AL; Peiris D; Zoega H; Pearson SA
    Aust N Z J Psychiatry; 2023 Jan; 57(1):49-57. PubMed ID: 35176912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant prescriptions and mental health nurses: an observational study in Dutch general practice from 2011 to 2015.
    Magnée T; de Beurs DP; Schellevis FG; Verhaak PF
    Scand J Prim Health Care; 2018 Mar; 36(1):47-55. PubMed ID: 29338537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription Drug Dispensing to US Children During the COVID-19 Pandemic.
    Chua KP; Volerman A; Conti RM
    Pediatrics; 2021 Aug; 148(2):. PubMed ID: 34285080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS.
    Martin A; Payne R; Wilson EC
    Appl Health Econ Health Policy; 2018 Jun; 16(3):317-330. PubMed ID: 29532329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using unemployment rates to predict prescribing trends in England.
    Pringle M; Morton-Jones A
    Br J Gen Pract; 1994 Feb; 44(379):53-6. PubMed ID: 8179946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal toxicity of antidepressants in England and Wales, 1993-2002.
    Morgan O; Griffiths C; Baker A; Majeed A
    Health Stat Q; 2004; (23):18-24. PubMed ID: 15704381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription of antidepressants by general practitioners: recommendations by FHSAs and health boards.
    Thakore JH; John DN
    Br J Gen Pract; 1996 Jun; 46(407):363-4. PubMed ID: 8983257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacoeconomic issues in the treatment of depression.
    Saklad SR
    Pharmacotherapy; 1995; 15(6 Pt 2):76S-83S. PubMed ID: 8587854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the COVID-19 pandemic on prescription drug use and costs in British Columbia: a retrospective interrupted time series study.
    Zeitouny S; McGrail K; Tadrous M; Wong ST; Cheng L; Law M
    BMJ Open; 2024 Jan; 14(1):e070031. PubMed ID: 38176877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant prescribing and changes in antidepressant poisoning mortality and suicide in England, 1993-2004.
    Morgan O; Griffiths C; Majeed A
    J Public Health (Oxf); 2008 Mar; 30(1):60-8. PubMed ID: 18239187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explaining variations in prescribing costs across England.
    Morton-Jones T; Pringle M
    BMJ; 1993 Jun; 306(6894):1731-4. PubMed ID: 8343631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liothyronine cost and prescriptions in England.
    Taylor PN; Razvi S; Muller I; Wass J; Dayan CM; Chatterjee K; Boelaert K
    Lancet Diabetes Endocrinol; 2019 Jan; 7(1):11-12. PubMed ID: 30577888
    [No Abstract]   [Full Text] [Related]  

  • 39. Variation in cost of newly qualified doctors' prescriptions: a review of data from a hospital electronic prescribing system.
    Nwulu U; Hodson J; Thomas SK; Westwood D; Griffin C; Coleman JJ
    Postgrad Med J; 2013 Jun; 89(1052):316-22. PubMed ID: 23515348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.